Compound 2012
Identifiers
- Canonical SMILES:
CC(=NNC(=O)c1cccc(C)c1)c1ccc2ccccc2c1O
- IUPAC name:
N'-[1-(1-hydroxynaphthalen-2-yl)ethylidene]-3-methylbenzohydrazide
- InChi:
InChI=1S/C20H18N2O2/c1-13-6-5-8-16(12-13)20(24)22-21-14(2)17-11-10-15-7-3-4-9-18(15)19(17)23/h3-12,23H,1-2H3,(H,22,24)
- InChiKey:
DIVLPCLMTPHBCQ-UHFFFAOYSA-N
External links
![]() 168317746 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
0 | 2 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
PCNA trimer | 6.17 | Stabilization |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 318.14 g/mol | |||
HBA | 4 | |||
HBD | 2 | |||
HBA + HBD | 6 | |||
AlogP | 4.01 | |||
TPSA | 61.69 | |||
RB | 3 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 0 | 2 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
10.1124/mol.112.077735 | PCNA-I8 | PCNA P12004 |
|
Cellular assay | cell growth inhibition PC-3 | PC-3 | pIC50 (half maximal inhibitory concentration, -log10) | 6.00 |
10.1124/mol.112.077735 | PCNA-I8 | PCNA P12004 |
|
Cellular assay | cell growth inhibition LNCaP | LNCaP | pIC50 (half maximal inhibitory concentration, -log10) | 6.17 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.7500 | 4-tert-butyl-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide | DB07097 | |
0.7333 | N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]naphthalene-2-carbohydrazide | DB06949 | |
0.7253 | (E)-3,4-DIHYDROXY-N'-[(2-METHOXYNAPHTHALEN-1-YL)METHYLENE]BENZOHYDRAZIDE | DB08034 | |
0.6989 | 3-bromo-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide | DB07044 | |
0.6989 | 4-bromo-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide | DB07098 | |
0.6667 | 4-chloro-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide | DB06950 | |
0.6633 | N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]-4-methoxybenzohydrazide | DB06978 | |
0.5614 | N'-[(1E)-(3,5-DIBROMO-2,4-DIHYDROXYPHENYL)METHYLENE]NICOTINOHYDRAZIDE | DB07445 | |
0.5596 | PAC-1 | DB13048 | |
0.5116 | 4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE | DB06884 | |
0.4390 | Benmoxin | DB09246 | |
0.4348 | Nifuroxazide | DB13855 | |
0.4296 | 3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol | DB03996 | |
0.4210 | Salicylamide | DB08797 | |
0.4144 | Onalespib | DB06306 |